Demographic and Clinical Factors Associated With Diagnostic Confidence in Interstitial Lung DiseaseTake-home Points by Mary Beth Scholand, MD, Sachin Gupta, MD, Kevin R. Flaherty, MD, Rosalinda V. Ignacio, MS, Zhongze Li, MS, Ayodeji Adegunsoye, MD

Get full text

Impact of Pirfenidone on Patient-Reported Outcomes in Patients With Idiopathic Pulmonary Fibrosis From the Pulmonary Fibrosis Foundation Patient RegistryTake-home Points by Mohleen Kang, MD, MS, Sachin Gupta, MD, Yi-Hsuan Tu, PhD, Karina Raimundo, MS, Anisha M. Patel, PhD, Kevin R. Flaherty, MD

Get full text

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Poin... by Steven D. Nathan, MD, Juergen Behr, MD, Vincent Cottin, MD, Lisa Lancaster, MD, Peter Smith, PharmD, CQ Deng, PhD, Natalie Breytenbach, PharmD, Heidi Bell, MD, Leigh Peterson, PhD, Kevin R. Flaherty, MD

Get full text